Midlands’ life-changing device
More than 30,000 patients with Type 1 diabetes across the UK Midlands now have access to life-changing continuous glucose monitoring technology, thanks to cost-effective deals
More than 30,000 patients with Type 1 diabetes across the UK Midlands now have access to life-changing continuous glucose monitoring technology, thanks to cost-effective deals
The US Food and Drug Administration has approved Abbott’s Proclaim XR spinal cord stimulation (SCS) system for the treatment of patients with diabetic peripheral neuropathy
Dexcom has announced that it has appointed Teri Lawver to its newly created role of chief commercial officer (CCO). Lawver’s position oversees the global commercial
Embecta has added an all-in-one, push-button fingerstick glucose reader to its portfolio. Launched this past April as a spinout from medtech giant BD, Embecta has
Diabeloop and EOFlow have announced that are partnering to offer the latter’s EOPatch system with automated insulin delivery in Europe. The partnership combines the EOPatch,
W8Buddy (WeightBuddy), a new digital support tool that can help patients achieve clinically meaningful weight loss, has been launched by University Hospitals Coventry and Warwickshire
Diabetes tech startup Harald AI has launched the popular Happy Bob App in Europe and in Canada, giving more ways for users of Dexcom Continuous
Beta Bionics has hired Steven Russell as chief medical officer. The change comes as Beta Bionics works to secure US Food and Drug Administration (FDA)
Need to figure out how much insulin to administer throughout the day and stick to those fluctuating doses over time? There’s now an app for
A retrospective study has linked participation in Onduo’s virtual program for managing Type 2 diabetes to reductions in blood glucose. Researchers at Quest Diagnostics analysed